openPR Logo
Press release

Healthcare CRO to Be the Prevailing Trend in the Botulinum Toxin Market

03-01-2022 07:11 AM CET | Health & Medicine

Press release from: Persistence Market Research

Healthcare CRO to Be the Prevailing Trend in the Botulinum Toxin

The Botulinum Toxin Market is likely to grow stupendously in the subsequent decade. With IoT in the picture, the complex medical equipment could be monitored, that too, all at a time and under one umbrella. As such, costly downtime could be avoided and predictive maintenance could be fostered. Plus, increased spending could be facilitated for disposable items like syringes, gloves, and masks.

As per Persistence Market Research's latest industry analysis, the global botulinum toxin market recorded market value of US$ 5.1 Bn in 2020, and is projected to expand at a CAGR of 6.9% over the forecast period of 2021-2031.

Botulinum toxin (onabotulinumtoxina) is a type of neurotoxin that is produced by the bacteria clostridium botulinum. The toxin comes in two forms - type A and type B. This toxin can be used for the treatment of muscle stiffness or spasms, migraine, hyperhidrosis, over reactive bladder, sialorrhea, and also for cosmetic use such as for skin wrinkles, forehead lines, crow's feet, frown lines, dermal fillers, and more.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/22990

The post-pandemic period experienced something called as the 'zoom-boom', wherein, most working professionals were constantly using applications for video conferencing such as Zoom, Google Meet, etc., which led them to become more aware about their looks. As such, cosmetic procedures such as Botox treatment, dermal fillers, and others experienced high demand.

For instance, according to the Aesthetic Society, the U.S. population spent more than US$ 9 Bn on plastic surgery in the year 2020.
Frequent approvals of various botulinum toxin products also leads to the cost-effective availability of these products in the market for consumers to choose from. This, in turn, led to growing demand for all kinds of Botox procedures around the world. Therapeutic procedures done using botulinum toxins are non-invasive, which makes them most sought-after.

For instance, in July 2020, Allergan PLC announced FDA approval of its product BOTOX®, a supplemental Biologics License Application (sBLA) for the treatment of muscle spasticity in the lower limbs in pediatric patients above 2 years of age who suffer from cerebral palsy.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/22990

Company Profiles:

Allergan PLC
U.S. WorldMeds
Hugh Source (International) Ltd.
Galderma laboratories.
Revance Therapeutics, Inc.
Ipsen Pharma
Merz Pharma GmbH & Co. KGaA
Daewoong Pharmaceuticals Co.,Ltd.
HUGEL Pharma
Medy-Tox Inc
Lanzhou Institute of Biological Products Co., Ltd
Teijin Pharma Ltd

Key Takeaways from Market Study

Botulinum toxin A, which can be used for various therapeutic as well as cosmetic dermatological procedures, leads the botulinum toxin market by capturing more than 98% share.
Therapeutic uses of this neurotoxin, such as prevention of migraine, and treatment of hyperhidrosis, sialorrhea, over reactive bladder, and muscle spasticity, are more popular than the cosmetic uses of the toxin, and thus, hold more than half of the total market share.
Specialty clinics are preferred more than hospitals, spas, or beauty clinics to undergo Botox procedures, and are expected to project a CAGR of 6.9% over the forecast period.
Nearly 60% of the global market share is accounted for by the North American region.

"Increased application of botulinum toxins for therapeutic and aesthetic purposes will propel market growth over the next few years," says an analyst of Persistence Market Research.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/22990

Market Competition

Key suppliers of botulinum toxin are focusing on forming strategic partnerships for marketing of their products, gaining approvals from various regulatory authorities around the world, and expanding their portfolios for gaining market foothold.

Merz Therapeutics collaborated with Teijin Pharma Ltd, in June 2021, for the marketing of Xeomin®, an incobotulinumtoxinA. In August 2021, it collaborated with Vensica Therapeutics for the innovation of needleless administration of botulinum neurotoxin for the management of over reactive bladder.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/botulinum-toxin-market.asp

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the botulinum toxin market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031.

The research study is based on the product (type A and type B), application (cosmetics (crow's feet, forehead lines, frawn lines/glabellar, square jaw/masseter, and others) and therapeutics (chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis and others)), and end user (hospitals, specialty clinics, and spa & beauty clinics), across seven key regions of the world.

Related Reports:

Soft Tissue Anchors Market - https://www.persistencemarketresearch.com/market-research/soft-tissue-anchors-market.asp

Facial Injectable Market - https://www.persistencemarketresearch.com/market-research/facial-injectable-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Healthcare CRO to Be the Prevailing Trend in the Botulinum Toxin Market here

News-ID: 2566534 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Botulinum

Botulinum Toxin in Urology Market Beyond Cosmetics: Botulinum Toxin's Growing Ro …
Botulinum Toxin in Urology Market worth $1,504.89 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Botulinum Toxin in Urology Market- (By Application (Overactive Bladder, Neurogenic Detrusor Overactivity), By End-use (Hospitals, Urology Clinics)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Botulinum Toxin in
Botulinum Toxin Growth Prospects, 2023-2030
According to Triton's analysis, the global botulinum toxin market garnered a value of $5796.12 million in 2022 and is estimated to progress at a CAGR of 10.17% during 2023-2030. A recent study by Triton Market Research titled Global Botulinum Toxin Market includes segmented by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users), Product Type (Type B, Type A), Application (Medical [Muscle Spasm, Hyperhidrosis, Overactive Bladder, Chronic Migraine, Other Medical
Botulinum Toxin: Growth Prospects 2023-2030
According to Triton's analysis, the global botulinum toxin market garnered a value of $5796.12 million in 2022 and is estimated to progress at a CAGR of 10.17% during 2023-2030. Read the Market Summary Here: https://www.tritonmarketresearch.com/reports/botulinum-toxin-market?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=TritonPR A recent study by Triton Market Research titled Global Botulinum Toxin Market includes segmented by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users), Product Type (Type B, Type A), Application (Medical [Muscle Spasm, Hyperhidrosis,
Botulinum Toxin: Growth Prospects 2023-2030
According to Triton's analysis, the global botulinum toxin market garnered a value of $5796.12 million in 2022 and is estimated to progress at a CAGR of 10.17% during 2023-2030. A recent study by Triton Market Research titled Global Botulinum Toxin Market includes segmented by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users), Product Type (Type B, Type A), Application (Medical [Muscle Spasm, Hyperhidrosis, Overactive Bladder, Chronic Migraine, Other
Botulinum Toxin: Growth Prospects 2023-2030
A recent study by Triton Market Research titled Global Botulinum Toxin Market includes segmented by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users), Product Type (Type B, Type A), Application (Medical [Muscle Spasm, Hyperhidrosis, Overactive Bladder, Chronic Migraine, Other Medical Applications], Aesthetic [Frown Lines/Glabellar, Square Jaw/Masseter, Forehead Lines, Crow's Feet, Other Aesthetic Applications]), Gender (Men, Women), and Regional Outlook (Latin America, Europe, North America, Middle East and Africa,
Botulinum Toxin: Growth Prospects 2023-2030
According to Triton's analysis, the global botulinum toxin market garnered a value of $5796.12 million in 2022 and is estimated to progress at a CAGR of 10.17% during 2023-2030. A recent study by Triton Market Research titled Global Botulinum Toxin Market includes segmented by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users), Product Type (Type B, Type A), Application (Medical [Muscle Spasm, Hyperhidrosis, Overactive Bladder, Chronic Migraine, Other